145 related articles for article (PubMed ID: 21800037)
41. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
[TBL] [Abstract][Full Text] [Related]
42. Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning.
Vessey DA; Li L; Honbo N; Karliner JS
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1429-35. PubMed ID: 19648253
[TBL] [Abstract][Full Text] [Related]
43. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart.
Schultz JE; Hsu AK; Gross GJ
Circ Res; 1996 Jun; 78(6):1100-4. PubMed ID: 8635241
[TBL] [Abstract][Full Text] [Related]
44. Comparison of three different A1 adenosine receptor antagonists on infarct size and multiple cycle ischemic preconditioning in anesthetized dogs.
Auchampach JA; Jin X; Moore J; Wan TC; Kreckler LM; Ge ZD; Narayanan J; Whalley E; Kiesman W; Ticho B; Smits G; Gross GJ
J Pharmacol Exp Ther; 2004 Mar; 308(3):846-56. PubMed ID: 14634049
[TBL] [Abstract][Full Text] [Related]
45. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts.
Schultz JE; Rose E; Yao Z; Gross GJ
Am J Physiol; 1995 May; 268(5 Pt 2):H2157-61. PubMed ID: 7771566
[TBL] [Abstract][Full Text] [Related]
46. Evidence for a role of opioids in epoxyeicosatrienoic acid-induced cardioprotection in rat hearts.
Gross GJ; Baker JE; Hsu A; Wu HE; Falck JR; Nithipatikom K
Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2201-7. PubMed ID: 20400686
[TBL] [Abstract][Full Text] [Related]
47. lschemic preconditioning in pigs: a causal role for signal transducer and activator of transcription 3.
Gent S; Skyschally A; Kleinbongard P; Heusch G
Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H478-H484. PubMed ID: 28039203
[TBL] [Abstract][Full Text] [Related]
48. Improved cardioprotection using a novel stepwise ischemic preconditioning protocol in rabbit heart.
Yamakawa K; Zhou W; Ko Y; Benharash P; Takemoto M; Mahajan A
J Surg Res; 2014 May; 188(2):381-6. PubMed ID: 24525060
[TBL] [Abstract][Full Text] [Related]
49. Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection.
Ruze A; Chen BD; Liu F; Chen XC; Gai MT; Li XM; Ma YT; Du XJ; Yang YN; Gao XM
Clin Sci (Lond); 2019 Mar; 133(5):665-680. PubMed ID: 30804219
[TBL] [Abstract][Full Text] [Related]
50. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning.
Halkos ME; Kerendi F; Corvera JS; Wang NP; Kin H; Payne CS; Sun HY; Guyton RA; Vinten-Johansen J; Zhao ZQ
Ann Thorac Surg; 2004 Sep; 78(3):961-9; discussion 969. PubMed ID: 15337028
[TBL] [Abstract][Full Text] [Related]
51. Eribis peptide 94 reduces infarct size in rat hearts via activation of centrally located μ opioid receptors.
Gross GJ; Hsu A; Nithipatikom K; Bobrova I; Bissessar E
J Cardiovasc Pharmacol; 2012 Feb; 59(2):194-7. PubMed ID: 22130105
[TBL] [Abstract][Full Text] [Related]
52. Influence of Hyperglycemia During Different Phases of Ischemic Preconditioning on Cardioprotection-A Focus on Apoptosis and Aggregation of Granulocytes.
Goergens JI; Heinen NM; Zoller J; Preckel B; Bauer I; Huhn R; Ebel D; Raupach A
Shock; 2020 May; 53(5):637-645. PubMed ID: 31306347
[TBL] [Abstract][Full Text] [Related]
53. The K(ATP) channel blocker HMR 1883 does not abolish the benefit of ischemic preconditioning on myocardial infarct mass in anesthetized rabbits.
Jung O; Englert HC; Jung W; Gögelein H; Schölkens BA; Busch AE; Linz W
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):445-51. PubMed ID: 10763861
[TBL] [Abstract][Full Text] [Related]
54. Possible role of JAK-2 in attenuated cardioprotective effect of ischemic preconditioning in hyperhomocysteinemic rat hearts.
Singh G; Rohilla A; Singh M; Balakumar P
Yakugaku Zasshi; 2009 May; 129(5):523-35. PubMed ID: 19420883
[TBL] [Abstract][Full Text] [Related]
55. Morphine preconditioning attenuates neutrophil activation in rat models of myocardial infarction.
Wang TL; Chang H; Hung CR; Tseng YZ
Cardiovasc Res; 1998 Dec; 40(3):557-63. PubMed ID: 10070497
[TBL] [Abstract][Full Text] [Related]
56. Protective effects of circulating microvesicles derived from ischemic preconditioning on myocardial ischemia/reperfusion injury in rats by inhibiting endoplasmic reticulum stress.
Liu M; Wang Y; Zhu Q; Zhao J; Wang Y; Shang M; Liu M; Wu Y; Song J; Liu Y
Apoptosis; 2018 Aug; 23(7-8):436-448. PubMed ID: 29980896
[TBL] [Abstract][Full Text] [Related]
57. Modulation of the cardioprotective effect of ischemic preconditioning in hyperlipidaemic rat heart.
Yadav HN; Singh M; Sharma PL
Eur J Pharmacol; 2010 Sep; 643(1):78-83. PubMed ID: 20598682
[TBL] [Abstract][Full Text] [Related]
58. BW373U86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation.
Patel HH; Hsu A; Moore J; Gross GJ
J Mol Cell Cardiol; 2001 Aug; 33(8):1455-65. PubMed ID: 11448134
[TBL] [Abstract][Full Text] [Related]
59. The significance of the washout period in preconditioning.
Salie R; Lochner A; Loubser DJ
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28118517
[TBL] [Abstract][Full Text] [Related]
60. Myocardial protection by ischemic preconditioning and delta-opioid receptor activation in the isolated working rat heart.
Karck M; Tanaka S; Bolling SF; Simon A; Su TP; Oeltgen PR; Haverich A
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):986-92. PubMed ID: 11689805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
